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Abstract The effect of expression of c-fos gene on proteoglycan 
synthesis, one of the important markers of cartilage metabolism, 
was examined by introducing the c-fos DNA into HCS 2/8 
cbondrocytes. The [3SS]sulfate incorporation into proteoglycan 
was decreased in the c-fos transfectants expressing exogenous c- 
fos mRNA, when compared to a control transfectant. A 
significant increase in transcription of MMP-3 with the 
suppressed transcription of aggrecan and TIMP-1 were also 
observed in the c-fos transfectants. Moreover, analysis of the 
effect of AP-I proteins on the collagenase and TIMP-1 
promoters in gastric carcinoma KKLS cells revealed that c-Fos 
combined with any of the Jun-related proteins failed to stimulate 
the TIMP-I promoter, though coUagenase promoter was 
effectively activated by any Fos/Jun-related protein heterocom- 
plex. These findings indicate that the c-fos expression may 
govern the cartilage metabolism and hence may play an 
important role in the pathogenesis of joint destruction in 
arthritis. 
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1. Introduction 
plied for such a progressive destruction of articular-cartilage 
matrix. 
Proteoglycan, one of the major component of cartilage ma- 
trix, could be an important marker of chondrocyte metabo- 
lism. Proteoglycan turnover is under control with an intricate 
balance between synthesis and degradation of the associated 
molecules. The degradation of proteoglycan is known to be 
controlled by both matrix metalloproteinases (MMP), espe- 
cially stromelysin (MMP-3), and tissue inhibitor of metallo- 
proteinase-1 (TIMP-1) [7,8]. It is possible to hypothesize that 
coordinated control over the expression of both MMP and 
TIMP is necessary for cartilage homeostasis, and that loss 
of this control mechanism, leading to an imbalance of degra- 
dative proteinases over protective TIMP activities, underlies 
the pathological tissue destruction in degenerative inflamma- 
tory diseases, like arthritis [9]. Since MMP-3 and TIMP-1 
DNA contain AP-l-binding site in the upstream region 
[8,10-12], it is likely that the overexpression of c-fos gene 
may affect proteoglycan turnover by regulating the MMP-3 
and TIMP-1 gene expression in chondrocytes. 
These consideration has prompted us to examine the role of 
c-fos gene in the proteoglycan metabolism of human chondro- 
cyte by transfecting human c-fos DNA into cultured chondro- 
cytes. 
The proto-oncogene c-fos is the cellular homologue of the 
v-fos which was originally obtained from the murine sarcoma 
virus [1,2]. Overexpression of c-fos in transgenic mice, carry- 
ing the exogenous mouse c-los gene under the control of the 
metallothionein promoter, deteriorated bone metabolism [3]; 
interfering with bone formation by inhibiting collagen syn- 
thesis in osteoblast [4] and enhancing osteoclast differentiation 
[5]. In addition, Kuroki et al. [5] reported that expression of c- 
fos caused the extensive fibroblastic outgrowth of human sy- 
novial mesenchymal cells. These findings have been consistent 
with the observation that the advancing edge of rheumatoid 
pannus extending into cartilage surface was mainly composed 
of fibloblast-like synovial cells, and also that the impaired 
bone formation and enhanced osteoclastic bone resorption 
have been seen in the rheumatoid juxtaarticular bone [6]. 
Therefore, the c-los gene has been considered playing a criti- 
cal role in the pathogenesis of joint destruction i  rheumatoid 
arthritis (RA). On the other hand, the concerted action of a 
number of matrix-degrading enzymes produced not only by 
synovial cells also by chondrocytes themselves has been ira- 
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2. Materials and methods 
2.1. Cell culture 
The human chondrosarcoma cell line HCS 2/8 cells (passage no. 
35-39) [13] and gastric carcinoma KKLS, a cell line established by 
Mai et al. (Kanazawa University) [14] were maintained in Dulbecco's 
modified Eagle's medium (DMEM; Nissui, Japan) containing 10% 
fetal bovine serum (FBS; HyClone, Logan) at 37°C in a humidified 
atmosphere of 5% COs in air. 
2.2. DNA construction 
pSV2neo-MT-hc-fos was obtained from pSV2neo, which was in- 
serted with the cadmium-inducible human metallothionein promoter 
(human MT2a) and human c-fos fragment in BamHI site. The frag- 
ment of human c-fos gene was isolated from c-fos pSPT18/19 [15] and 
mRNA destabilizing sequence [16,17] in its 3' non-coding region was 
removed before insertion. 
A self-ligation product of the pSV2neo-MT was used as a control. 
Human MT2a and pSV2neo were the gifts from Dr. T. Tokuhisa, 
Chiba University School of Medicine, and human c-fos pSPT18/19 
was purchased from Japanese Cancer Research Resources Bank 
(JCRB, CO 054). 
2.3. DNA transfection 
DNA transfection was carried out by the electroporation method 
[18]. Following G418 selection, the resistant cells were cloned. Pre- 
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sence of the transfected human c-fos gene was examined by polymer- 
ase chain reaction (data not shown). 
2.4. Northern blot analysis 
The total RNA was extracted from cultured cells by the acid gua- 
nidinium thiocyanate-phenol-chloroform (AGPC) method [19]. 15 ~tg 
of total RNA was denatured, separated by electrophoresis in 1% 
agarose-formaldehyde gels, transferred to Hybond N + nylon mem- 
branes (Amersham, Japan) and hybridized with the appropriate 
probes. 
2.5. Hybridization probe 
The probes for human c-fos (1.4-kb EcoRI-AccI fragment of the 
human c-fos DNA obtained from the JCRB), metaUoproteinase 3 
(MMP-3) (1.4-kb SacI-Xhol fragment of cDNA), tissue inhibitor of 
metalloproteinase 1 (TIMP-1) (0.6-kb Clal-BamHI fragment of 
cDNA) and the 1.2-kb I]-actin were labeled with [ct-32p]dCTP by 
nick translation method and hybridized at 42°C in 50% formamide 
solution. After hybridization, the filter was washed in 0.1% sodium 
dodecyl sulfate (SDS) and 1 x standard saline citrate (SSC) at 42°C. 
Probe-specific for aggrecan (nucleotides 1096-1120) of cDNA re- 
ported by Baldwin et al. [201, 5'-CTCGTGCCAGATCATCACCAC- 
ACAT-3' was synthesized with a DNA synthesizer (Applied Biosys- 
tems, Foster City, CA) and purified on an acrylamide gel. The 
oligonucleotide probe was end-labeled with [y-32p]ATP using T4 poly- 
nucleotide kinase and hybridized in 20% formamide solution (20% 
formamide, 5×SSPE (0.15 M NaC1, 10 mM NaH~PO4, 1 mM 
EDTA), 5% SDS) at 54°C. The blots were washed in 2 × SSPE and 
1% SDS at 54°C to eliminate partial hybridization and to maintain 
specific hybridization of the complete 25-bp oligonucleotide. 
2.6. Determination of proteoglycan synthesis 
Proteoglycan synthesis was monitored by determining the 
[asS]sulfate incorporation as previously described [21]. After chondro- 
cytes were grown to confluency, they were preincubated in 0.1 ml of 
the DMEM containing 0.3% FBS for 24 h. The cells were then in- 
cubated for 6-12 h with 5 p.M of CdCI2 in 0.1 ml of DMEM with 
0.3% FBS, and 5 ktl of DMEM supplemented with 100 ktCi/ml of 
[asS]sulfate was added 6 h before the end of incubation. The media 
was then removed and the cell layers were solubilized with 0.5 N 
NaOH. The media and cell fractions were combined and neutralized 
with 6 N HC1. Proteoglycan synthesis was determined by measuring 
incorporation of [3~S]sulfate into the mixtures precipitated with cetyl- 
pyridinium chloride (CPC) after treatment with Pronase E. Data was 
expressed as the mean+S.D. Statistical analyses were carried out by 
Student's t test. 
2. 7. Determination of DNA 
DNA content was determined by a standard fluorometric procedure 
[221. 
2.8. Relative hydrodynamic sizes of proteoglycan 
Cells were seeded at a density of 1 × 105 cells/35-mm plastic culture 
dish and cultured for 10 days in DMEM containing 10% FBS. They 
were then incubated for 12 h in the presence or absence of 5 ~tM of 
CdCI2 in 1 ml of DMEM containing 10% FBS. 10 I.tl of DMEM 
supplemented with 100 I.tCi of [SaS]sulfate was added 6 h before the 
end of incubation. The medium was kept frozen at -70°C until ana- 
lyzed. The cell layers were overlaid with 1.0 ml of 50 mM Tris-HC1 
(pH 8.0) buffer containing 4 M guanidine HC1, 1 mM iodoacetic acid, 
1 mM phenylmethylsulfonyl fluoride, 0.1 M 6-amino-n-caproic a id, 
20 mM EDTA, and 1 mg/ml benzamidine HC1. The culture dishes 
were then put on a shaker for 24 h at 4°C. After the clarification by 
centrifugation (4000xg for 15 min), the cell extracts were stored at 
-70°C until analyzed. Aliquots (0.5 ml) of the medium were mixed 
with 0.5-ml aliquots of the respective cell extracts and 1.0 ml of 8 M 
guanidine in water. The mixtures were applied to a Sepharose CL-2B 
column (1.6X96 cm) equilibrated in 4 M guanidine HC1, 50 mM Tris- 
HCI buffer, pH 8.0, with protease inhibitors. 
2.9. Analysis of the TIMP-1 and collagenase promoter activity 
Construction of expression plasmids and promoter plasmids have 
been described previously [12,23]. Briefly, expression plasmids for c- 
Jun, JunB, JunD, c-Fos, Fra-1 and Fra-2 were constructed by insert- 
223 
ing the coding regions of human c-jun, jun B, jun D, c-fos, fra-1 and 
fra-2 genes, respectively, into cloning sites of the pSG5 vector. Pro- 
moter plasmids, collagenase promoter-CAT and TIMP-1 promoter- 
CAT, were constructed by fusing the collagenase and TIMP-1 pro- 
moters, respectively, to the chloramphenicol acetyltransferase (CAT) 
structural gene. For transfection, KKLS cells were seeded at 2 × l0 s 
cells/40-mm dish, and cultured for 16 h in DMEM containing 5% 
FBS. Promoter CAT plasmids (2-10 p.g) were co-transfected with or 
without 1 txg of the expression plasmids by calcium phosphate co- 
precipitation. After a 36-h incubation, the cells were harvested and 
CAT activity was determined [24]. Radioactive spots were quantified 
with a Bioimage analyzer BAS 2000 (Fuji Film) 
3. Results and discussion 
The time course of  c-fos mRNA expression after induction 
by cadmium chloride (CdC12) was examined by Northern blot 
analysis (Fig. 1). The expression of c-fos mRNA was induced 
in pSV2neo-MT-hc-fos transfectants (t"2-, f5 and f17) after in- 
duction by 5 × 10 -6 M cadmium. The message pattern showed 
the two bands with different sizes which were considered the 
c-fos messages, since these bands were consistently confirmed 
at the same locations in Northern blots using another human 
c-fos probe (data not shown). Interestingly, Riather et al. pre- 
viously reported when human MT2a promoter and c-fos to- 
gether with a part of the polyoma virus early region 3' were 
introduced into embryonal carcinoma cells, similar pattern of 
c-fos mRNA was observed in some transfectants, which was 
found to contain more than 100 copies of the exogenous c-fos 
DNA [25]. Thus, it is possible that the pattern of  c-fos mRNA 
in t"2, f5 and f17 may be due to, at least in part, the high copy 
numbers of exogenous c-fos gene constructs. The band in 
HCS 2/8 and C5 transfectant at 12 h after the cadmium in- 
duction may represent he endogenous c-fos mRNA.  Zhu et 
al. have reported that the expression of c-fos mRNA was 
increased in HCS 2/8 cells as the cells grown over confluency 
[26]. In the sparse and subconfluent phases of culture, this 
band could not be found either in HCS 2/8 or C5 transfectant 
at 12 h after the cadmium induction. 
HCS Z/8 Oh 6h 12h 
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Fig. 1. Time course of c-fos mRNA expression after cadmium in- 
duction. 15 I.tg of total RNA was extracted from untransfected HCS 
2/8 cells, pSV2neo-MT transfectant (c5) and pSV2neo-MT-hc-fos 
transfectants (t2, f5 and f17) at the times indicated in the figure as 
described in section 2. Equivalent amounts of total RNAJwell were 
assessed by monitoring the I]-actin mRNA. SP, in the sparse and 
OC, overconfluent phases of culture. 
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Fig. 2. Sepharose CL-2B chromatography of proteoglycans from 
cultures with (broken line) or without (solid line) cadmium induc- 
tion. Cells were seeded and exposed to [3~S]sulfate asdescribed in 
section 2. Portions (I ml) of mixtures of the cell extract fraction 
and the medium from cultures were applied on a column of Sephar- 
ose CL-2B equilibrated in 4 M guanidine HC1, 50 mM Tris-HCl 
buffer, pH 8.0, with protease inhibitors. Aliquots (0.3 ml) of each 
fraction (3 ml) were mixed with 0.3 ml of ethanol and 10 ml of 
Aquasol. Radioactivity was measured in a LKB scintillation coun- 
ter. Free unincorporated radioactivity eluted at Vt. V0 represented 
the void volume. (A) Untransfected HCS 2/8 cells; (B) pSV2neo- 
MT transfectant (c5); (C, D and E) pSV2neo-MT-hc-fos transfec- 
tants f2, f5 and fl 7, respectively. 
Proteoglycan synthesis was estimated in the pSV2neo-MT- 
hc-fos transfectants, pSV2neo-MT transfectant and also in 
untransfected HCS 2/8 cells by measuring incorporation of 
[3~S]sulfate into proteoglycan precipitated with CPC after pro- 
nase digestion. The rate of [35S]sulfate incorporation i to pro- 
teoglycan was significantly decreased after the cadmium in- 
duction in f2, f5 and f17 transfectants, while normal amount 
of proteoglycan was synthesized in C5 transfectant, which did 
not express exogenous c-fos mRNA (Table 1). Next, we ana- 
lyzed the hydrodynamic sizes of ass-labeled proteoglycans by 
gel chromatography on Sepharose CL-2B. The elution profiles 
are shown in Fig. 2. Chondrocytes produce two proteoglycan 
population with different sizes: a large proteoglycan, aggre- 
can, characteristically found in the cartilage matrix and small 
proteoglycans found in both non-chondrogenic and chondro- 
genic cells. [35S]sulfate incorporation i to the large proteogly- 
can was significantly decreased after the cadmium induction in 
f2, f5 and fl 7 transfectants, while no significant change could 
be seen in C5 transfectant. The reduction of [35S]sulfate in- 
corporation in the large proteoglycan was greater than that in 
the small proteoglycan. These changes were coincident with 
the expression of exogenous c-fos mRNA. Though c-fos may 
have various effects on the regulation of proteoglycan meta- 
bolism, there are two major reasons to cause the observed 
decrement of the proteoglycan synthesis in the pSV2neo- 
MT-hc-fos transfectants; either the repression of aggrecan 
gene transcription by c-Fos or the digestion of the proteogly- 
can by MMP, especially by stromelysin (MMP-3) produced 
excessively in the pSV2neo-MT-hc-fos transfectants, ince 
MMP-3 gene also contain AP-1 sites in its upstream promoter 
position. 
Changes in expression of aggrecan mRNA were analyzed 
by Northern blot hybridization (Fig. 3B). Expression of ag- 
grecan mRNA started to decrease 6 h after cadmium induc- 
tion in f2, f5 and fl 7 transfectants but not in c5 or HCS 2/8 
cells. Furthermore, in order to assess the influence of the 
degradation activities of MMP over the decrement of aggre- 
can synthesis in pSV2neo-MT-hc-fos transfectants, expression 
of MMP-3 and TIMP-1 mRNA were monitored by Northern 
blot analysis (Fig. 3A). The level of MMP-3 mRNA in f2, f5 
and f17 transfectants was increased 6 h after cadmium induc- 
tion. On the other hand, the level of TIMP-1 mRNA ap- 
peared to decrease significantly in f2, f5 and fl 7 transfectants 
at 6 h after the cadmium induction. 
The finding that transfection with self-ligated 
HCS 2/8 Oh 6h 12h 
0 6h 12h c5 t2 f5 f17 c5 f2 t5 f17 c5 f'2 P5 1"17 
MMP-3 
TIMP-1 
!ii~iii~i~i~ ¸ ~i~ 
B 
proteogh/c ln  
Fig. 3. Northern blot analysis of MMP-3, TIMP-1 and proteoglycan 
mRNA after cadmium induction. The same filters as in Fig. 1 were 
used for blotting with MMP-3, TIMP-1 (A) and proteoglycan (ag- 
grecan) (B) probes. HCS 2/8, untransfected HCS 2/8 cells in the 
confluent phase, c5, pSV2neo-MT transfectant in the confluent 
phase; f2, f5 and f17, pSV2neo-MT-hc-fos transfectants. 
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Fig. 4. Effect of AP-1 on the collagenase and TIMP-I promoter 
genes. Promoter activity was analyzed by transient transfection as- 
say using KKLS cells. Cells were co-transfected with 1 I.tg each of 
c-Jun, JunB, JunD, c-Fos, Fra-1 and Fra-2 expression plasmids, 
and 2-10 ~g each of promoter plasmids, collagenase promoter-CAT 
and TIMP-1 promoter-CAT. The cells were harvested, and CAT ac- 
tivity was analyzed 36 h after the transfections. Lane 1, transfected 
with promoter plasmids; co-transfected with promoter plasmids 
and; c-Jun expression plasmid (lane 2, C); JunB expression plasmid 
(lane 3, B); JunD expression plasmid (lane 4, D); c-Jun and c-Fos 
expression plasmids (lane 5); JunB and c-Fos expression plasmids 
(lane 6); JunD and c-Fos expression plasmids (lane 7); c-Jun and 
Fra-1 expression plasmids (lane 8); JunB and Fra-1 expression plas- 
mids (lane 9); JunD and Fra-1 expression plasmids (lane 10); c-Jun 
and Fra-2 expression plasmids (lane I 1); JunB and Fra-2 expression 
plasmids (lane 12); JunD and Fra-2 expression plasmids (lane 13). 
Each experiment was performed in triplicate, and representative re-
sults are shown. 
vector affected neither proteoglycan synthesis nor the tran- 
scription of aggrecan, MMP-3 and TIMP-1 genes, indicates 
that SV40 enhancer and MT sequences are irrelevant with the 
inhibition of proteoglycan synthesis. It is, therefore, supposed 
that aggrecan synthesis in HCS 2/8 chondrocytes i  under the 
control of transacting c-fos gene, as shown by decreased tran- 
scription of aggrecan and TIMP-1, and by increased tran- 
scription of MMP-3. 
Recently, several ines of evidence suggest hat c-Fos, the 
product of the c-fos, together with c-Jun protein or its related 
proteins (JunB or JunD) represents the transcription factor 
AP-I (activating protein-l). These may act as intracellular 
messengers that convert short-term signals generated by ex- 
tracellular stimuli nto long-term changes in cell phenotype by 
regulating the expression of downstream genes that possess 
Table 1 
Proteoglycan synthesis in transfectants 
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AP-l-binding site [11]. The AP-1 sequences were found in the 
promoters of many genes, including human collagenase, 
MMP-3 and TIMP-1. Although it is well-documented that 
collagenase and MMP-3 were induced through the AP-I path- 
way, controversy exists concerning its effect on TIMP-I  [27- 
29]. In order to assess the effect of AP-1 proteins on the 
expression of collagenase and TIMP- I ,  the promoter CAT 
plasmids, collagenase-CAT or TIMP-1-CAT, were transfected 
into recipient KKLS cells with or without the expression plas- 
mids for c-Jun, JunB, JunD, c-Fos, Fra-1 or Fra-2. Then, the 
CAT activity was analyzed to monitor collagenase and TIMP- 
1 promoters activity (Fig. 4). This particular cell line was used 
here because activation by AP-1 proteins can be readily ob- 
served in these cells due to their low basal promoter activity as 
described previously [12]. The collagenase promoter was 
clearly activated by Jun-related proteins as well as Fos/Jun- 
related protein heterocomplex. On the other hand, c-Fos com- 
bined with any of the Jun-related proteins failed to stimulate 
the TIMP-1 promoter, although this promoter was also acti- 
vated by Fra-1 or Fra-2/Jun-related protein heterocomplex. 
Furthermore, c-Fos inhibited the activation of TIMP-1 pro- 
moter by JunD. 
In this study, we have demonstrated that introduction of 
exogenous c-fos DNA in HCS 2/8 chondrocytes resulted in 
the decreased endogenous transcription of proteoglycan and 
TIMP-1, and the increased transcription of MMP-3. It was 
also shown that c-Fos-regulated TIMP-1 promoter negatively 
in a transient transfection assay with KKLS cells while other 
AP-1 proteins were positive regulators. This is the first de- 
monstration of the repressive ffect of c-Fos on TIMP-1 pro- 
moter, although its inducing effect on collagenase and MMP-3 
promoters has been shown previously [23]. Thus, the c-Fos 
may cause a similar effect on TIMP-1 and MMP-3 promoters 
in HCS 2/8 chondrocytes. This possibility is now under inves- 
tigation. 
These results taken together may indicate that the c-fos 
gene plays an important role not only in the cartilage home- 
ostasis also in the pathogenesis of cartilage destruction in 
patients with arthritis. 
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HCS 2/8 (-) 9.77 + 0.08 8.75 + 1.00 89.6 + 10,2 
c5 (-) 10.47 + 3.38 10.71 + 1.02 102.3 + 9.7 
f2 (+) 8.51 + 0.72 7.78 + 0.52 91.4 + 6.1 
f5 (+) 10.88 + 10.8 10.74 + 0.88 98.7 + 8.1 
f17 (+) 9.58 + 0.10 8.09 + 0.68 84.4 + 7.1 
HCS 2/8 (-) 9.98 + 0.13 9.85 + 0.96 98.7 + 9.6 
c5 (-) 11.07 + 0.32 10.37 + 1.32 93.7 +_ 11.9 
f2 (+) 9.78 +- 0.68 4.31 + 0.38* 44,1 _+ 3.9 
f5 (+) 11.08 -+ 0.37 5.35 + 1.00" 48,3 -+ 9.0 
f17 (+) 10.70 + 0.62 3.89 +- 0.75* 36.4 -+ 7.0 
The ceils were incubated for 6-12 h with 5 IxM/ml of CdC12 in 0.1 ml of 0.3% FCS/DME medium. The cultures were labeled with [35S]sulfate 
(0.5 laCi) for the last 6 h before the end of incubation. Each value represents he mean +- S.D. for six dishes. HCS 2/8, HCS 2/8 chondrocyte; 
c, control pSV2neo-MT transfectant; f, pSV2neo-MT-hc-fos transfectant. *P < 0.01 by the Student's t-test as compared with cadmium induc- 
tion (-) in each group. 
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